Itamar Medical Ltd (ITMR):企業の財務・戦略的SWOT分析

◆英語タイトル:Itamar Medical Ltd (ITMR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME4830FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥79,200見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥118,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, manufactures, and markets non-invasive medical devices for the diagnosis of cardiology disease and sleep related breathing disorders. It develops products using its proprietary peripheral arterial tonometry (PAT) technology that measures changes in patient’s pulsatile arterial volume. Its flagship products include EndoPAT, an endothelial function assessment tool to assess the risk of heart disease and other cardiovascular diseases; and WatchPAT, a home-use diagnostic device for sleep breathing disorders. It has collaboration with leading sleep physicians and industry partners. The company has operations in Israel, the Netherlands, Japan and the US. Itamar Medical is headquartered in Caesarea, Israel.

Itamar Medical Ltd Key Recent Developments

Feb 16,2021: Itamar Medical to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Tuesday, March 2, 2021
Feb 11,2021: Itamar Medical to Participate in Upcoming Investor Conferences
Jan 27,2021: Itamar Medical appoints Scott P. Serota to its board of directors
Jan 07,2021: Itamar Medical announces preliminary revenue results for fourth quarter and full year 2020
Nov 17,2020: Itamar Medical reports record third quarter 2020 revenues

This comprehensive SWOT profile of Itamar Medical Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Itamar Medical Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Itamar Medical Ltd – Key Information
Itamar Medical Ltd – Overview
Itamar Medical Ltd – Key Employees
Itamar Medical Ltd – Key Employee Biographies
Itamar Medical Ltd – Key Operational Heads
Itamar Medical Ltd – Major Products and Services
Itamar Medical Ltd – History
Itamar Medical Ltd – Company Statement
Itamar Medical Ltd – Locations And Subsidiaries
Itamar Medical Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Itamar Medical Ltd – Business Description
Itamar Medical Ltd – Corporate Strategy
Itamar Medical Ltd – SWOT Analysis
SWOT Analysis – Overview
Itamar Medical Ltd – Strengths
Itamar Medical Ltd – Weaknesses
Itamar Medical Ltd – Opportunities
Itamar Medical Ltd – Threats
Itamar Medical Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Itamar Medical Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Itamar Medical Ltd, Key Information
Itamar Medical Ltd, Key Ratios
Itamar Medical Ltd, Share Data
Itamar Medical Ltd, Major Products and Services
Itamar Medical Ltd, History
Itamar Medical Ltd, Key Employees
Itamar Medical Ltd, Key Employee Biographies
Itamar Medical Ltd, Key Operational Heads
Itamar Medical Ltd, Other Locations
Itamar Medical Ltd, Subsidiaries
Itamar Medical Ltd, Key Competitors
Itamar Medical Ltd, SWOT Analysis
Itamar Medical Ltd, Ratios based on current share price
Itamar Medical Ltd, Annual Ratios
Itamar Medical Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Itamar Medical Ltd (ITMR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Catalyst Biosciences Inc (CBIO)-医療機器分野:企業M&A・提携分析
    Summary Catalyst Biosciences Inc (Catalyst), formerly Targacept Inc is a clinical-stage biopharmaceutical company that develops novel medicines to address hematology indications. The company discovers and develops next generation biopharmaceuticals based on engineered human proteases platform techno …
  • NanoViricides Inc (NNVC)-製薬・医療分野:企業M&A・提携分析
    Summary NanoViricides Inc (NanoViricides), formerly Edot-com.com Inc is a biopharmaceutical company that provides nanomedicine technology solutions. The company conducts research in the areas of medical science and pharmaceutical technology such as polymeric micelles, multi-specific multi-targeting, …
  • Joint Stock Commercial Bank for Foreign Trade of Vietnam (VCB):企業の財務・戦略的SWOT分析
    Joint Stock Commercial Bank for Foreign Trade of Vietnam (VCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the c …
  • Grand Haven Board of Light and Power:企業の戦略的SWOT分析
    Grand Haven Board of Light and Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • JGC Corp (1963):電力:M&Aディール及び事業提携情報
    Summary JGC Corp (JGC) is an engineering contracting company. It offers engineering, procurement and construction services for various engineering contracts and projects in the areas of oil and gas development, petroleum refining, natural gas processing, petrochemicals, clean energy and power genera …
  • Hays plc (HAS):企業の財務・戦略的SWOT分析
    Hays plc (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Ovensa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ovensa Inc (Ovensa) is a preclinical stage company that develops nanotherapeutics. The company uses its proprietary Triozan Nanomedicine delivery platform that has mucosal and brain-barrier crossing properties used in treatment of oncology and neurodegenerative diseases. Its Triozan helps in …
  • Evergreen Fibreboard Berhad:企業の戦略・SWOT・財務情報
    Evergreen Fibreboard Berhad - Strategy, SWOT and Corporate Finance Report Summary Evergreen Fibreboard Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Shadin Avionics LP:企業の戦略・SWOT・財務分析
    Shadin Avionics LP - Strategy, SWOT and Corporate Finance Report Summary Shadin Avionics LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pure Technologies Ltd:企業の戦略的SWOT分析
    Pure Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Exelon Corporation (EXC)-エネルギー分野:企業M&A・提携分析
    Summary Exelon Corporation (Exelon) is a utility services holding company operating across the energy value chain comprising power generation, distribution, transmission and energy sales. It generates electricity from diverse sources, including nuclear, fossil fuels and renewable energy. Exelon deli …
  • Lee’s Pharmaceutical Holdings Ltd (950):製薬・医療:M&Aディール及び事業提携情報
    Summary Lee's Pharmaceutical Holdings Ltd (Lee's Pharmaceutical) is a biopharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematology …
  • Repsol, S.A.:企業の戦略・SWOT・財務情報
    Repsol, S.A. - Strategy, SWOT and Corporate Finance Report Summary Repsol, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Fusion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Fusion Pharmaceuticals Inc (Fusion Pharmaceuticals) is a clinical-stage biopharmaceutical company which develops targeted alpha-particle radio therapeutics for the treatment of chemotherapy resistant cancers. Its pipeline product includes FPX-01, a radiolabeled antibody designed to internali …
  • Samsung Securities Co Ltd (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co Ltd (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Daewoo Shipbuilding & Marine Engineering Co Ltd:戦略・SWOT・企業財務分析
    Daewoo Shipbuilding & Marine Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Daewoo Shipbuilding & Marine Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Altri SGPS SA (ALTR):企業の財務・戦略的SWOT分析
    Altri SGPS SA (ALTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Welltower Inc:企業の戦略・SWOT・財務分析
    Welltower Inc - Strategy, SWOT and Corporate Finance Report Summary Welltower Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Eone Diagnomics Genome Center Co Ltd (245620):企業の製品パイプライン分析
    Summary Eone Diagnomics Genome Center Co Ltd (EDGC) develops genome analysis technology solutions. The company focuses on the development of clinical genomic products for non-invasive prenatal test; newborn genetic screening test, hereditary cancer prediction test, female cancer prediction test and …
  • Sleep Number Corp (SNBR):企業の財務・戦略的SWOT分析
    Sleep Number Corp (SNBR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆